SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 139 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $222,000 | -70.5% | 11,542 | -73.3% | 0.03% | -67.3% |
Q1 2022 | $753,000 | +41.3% | 43,300 | +80.7% | 0.10% | +16.1% |
Q4 2020 | $533,000 | -3.4% | 23,958 | -36.0% | 0.09% | -5.4% |
Q3 2020 | $552,000 | +173.3% | 37,420 | +62.4% | 0.09% | +283.3% |
Q4 2019 | $202,000 | -11.8% | 23,041 | -6.1% | 0.02% | -7.7% |
Q2 2019 | $229,000 | +186.2% | 24,550 | +60.2% | 0.03% | +225.0% |
Q1 2019 | $80,000 | -78.3% | 15,323 | -70.8% | 0.01% | -55.6% |
Q2 2018 | $368,000 | – | 52,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |